These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24336963)

  • 21. Discovery of
    Mologni L; Dalla Via M; Chilin A; Palumbo M; Marzaro G
    ChemMedChem; 2017 Aug; 12(16):1390-1398. PubMed ID: 28639308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis.
    Nakao KT; Usui T; Ikeda M; Mori Y; Yamamoto T; Kawashima ST; Nanba K; Yuno A; Tamanaha T; Tagami T; Naruse M; Asato R; Shimatsu A
    Head Neck; 2013 Dec; 35(12):E363-8. PubMed ID: 23468374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of ZAP70 inhibitors by high-throughput docking into a conformation of its kinase domain generated by molecular dynamics.
    Zhao H; Caflisch A
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5721-6. PubMed ID: 23993776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of tyrosine kinase inhibitors by docking into an inactive kinase conformation generated by molecular dynamics.
    Zhao H; Huang D; Caflisch A
    ChemMedChem; 2012 Nov; 7(11):1983-90. PubMed ID: 22976951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance profiles of mutations in the RET kinase domain.
    Liu X; Shen T; Mooers BHM; Hilberg F; Wu J
    Br J Pharmacol; 2018 Sep; 175(17):3504-3515. PubMed ID: 29908090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease-causing mutation in extracellular and intracellular domain of FGFR1 protein: computational approach.
    Rajith B; George Priya Doss C
    Appl Biochem Biotechnol; 2013 Mar; 169(5):1659-71. PubMed ID: 23329143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors.
    Shih KC; Shiau CW; Chen TS; Ko CH; Lin CL; Lin CY; Hwang CS; Tang CY; Chen WR; Huang JW
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4490-7. PubMed ID: 21724393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico 3D structure modeling and inhibitor binding studies of human male germ cell-associated kinase.
    Tanneeru K; Balla AR; Guruprasad L
    J Biomol Struct Dyn; 2015; 33(8):1710-9. PubMed ID: 25245460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Pyrazolo[3,4-d]pyrimidin-4-amine Derivative Containing an Isoxazole Moiety Is a Selective and Potent Inhibitor of RET Gatekeeper Mutants.
    Yoon H; Kwak Y; Choi S; Cho H; Kim ND; Sim T
    J Med Chem; 2016 Jan; 59(1):358-73. PubMed ID: 26652860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing Dynamic Structure-Based Pharmacophore and ML-Trained QSAR Models for the Discovery of Novel Resistance-Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis.
    Sayyah E; Oktay L; Tunc H; Durdagi S
    ChemMedChem; 2024 Jun; 19(12):e202300644. PubMed ID: 38523069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and validation of a RET TK catalytic domain by homology modeling.
    Tuccinardi T; Manetti F; Schenone S; Martinelli A; Botta M
    J Chem Inf Model; 2007; 47(2):644-55. PubMed ID: 17295463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2.
    Ahmed M; Sadek MM; Abouzid KA; Wang F
    J Mol Graph Model; 2013 Jul; 44():220-31. PubMed ID: 23911931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leveraging Atropisomerism to Obtain a Selective Inhibitor of RET Kinase with Secondary Activities toward EGFR Mutants.
    Toenjes ST; Garcia V; Maddox SM; Dawson GA; Ortiz MA; Piedrafita FJ; Gustafson JL
    ACS Chem Biol; 2019 Sep; 14(9):1930-1939. PubMed ID: 31424197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammal-restricted elements predispose human RET to folding impairment by HSCR mutations.
    Kjaer S; Hanrahan S; Totty N; McDonald NQ
    Nat Struct Mol Biol; 2010 Jun; 17(6):726-31. PubMed ID: 20473317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A secondary RET mutation in the activation loop conferring resistance to vandetanib.
    Nakaoku T; Kohno T; Araki M; Niho S; Chauhan R; Knowles PP; Tsuchihara K; Matsumoto S; Shimada Y; Mimaki S; Ishii G; Ichikawa H; Nagatoishi S; Tsumoto K; Okuno Y; Yoh K; McDonald NQ; Goto K
    Nat Commun; 2018 Feb; 9(1):625. PubMed ID: 29434222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, modeling, and RET protein kinase inhibitory activity of 3- and 4-substituted beta-carbolin-1-ones.
    Cincinelli R; Cassinelli G; Dallavalle S; Lanzi C; Merlini L; Botta M; Tuccinardi T; Martinelli A; Penco S; Zunino F
    J Med Chem; 2008 Dec; 51(24):7777-87. PubMed ID: 19053769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and dynamic determinants for highly selective RET kinase inhibition reveal cryptic druggability.
    Shehata MA; Contreras J; Martín-Hurtado A; Froux A; Mohamed HT; El-Sherif AA; Plaza-Menacho I
    J Adv Res; 2023 Mar; 45():87-100. PubMed ID: 35595215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and chemical inhibition of the RET tyrosine kinase domain.
    Knowles PP; Murray-Rust J; Kjaer S; Scott RP; Hanrahan S; Santoro M; Ibáñez CF; McDonald NQ
    J Biol Chem; 2006 Nov; 281(44):33577-87. PubMed ID: 16928683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking the interaction between HIV-1 integrase and human LEDGF/p75: mutational studies, virtual screening and molecular dynamics simulations.
    Reddy KK; Singh P; Singh SK
    Mol Biosyst; 2014 Mar; 10(3):526-36. PubMed ID: 24389668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of 4-chloro-3-(5-(pyridin-3-yl)-1,2,4-oxadiazole-3-yl)benzamides as novel RET kinase inhibitors.
    Han M; Li S; Ai J; Sheng R; Hu Y; Hu Y; Geng M
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5679-5684. PubMed ID: 27815117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.